<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-17" modified="2020-10-07" version="150">
<accession>Q86YC2</accession>
<accession>A6NIE1</accession>
<accession>Q8N7Y6</accession>
<accession>Q8ND31</accession>
<accession>Q9H6W1</accession>
<name>PALB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Partner and localizer of BRCA2</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">PALB2</name>
<name type="synonym">FANCN</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Endometrium</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-440 AND 476-1186</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="719" last="729">
<title>Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.</title>
<authorList>
<person name="Xia B."/>
<person name="Sheng Q."/>
<person name="Nakanishi K."/>
<person name="Ohashi A."/>
<person name="Wu J."/>
<person name="Christ N."/>
<person name="Liu X."/>
<person name="Jasin M."/>
<person name="Couch F.J."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="16793542"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.05.022"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BRCA2</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Nature" volume="446" first="316" last="319">
<title>A recurrent mutation in PALB2 in Finnish cancer families.</title>
<authorList>
<person name="Erkko H."/>
<person name="Xia B."/>
<person name="Nikkilae J."/>
<person name="Schleutker J."/>
<person name="Syrjaekoski K."/>
<person name="Mannermaa A."/>
<person name="Kallioniemi A."/>
<person name="Pylkaes K."/>
<person name="Karppinen S.-M."/>
<person name="Rapakko K."/>
<person name="Miron A."/>
<person name="Sheng Q."/>
<person name="Li G."/>
<person name="Mattila H."/>
<person name="Bell D.W."/>
<person name="Haber D.A."/>
<person name="Grip M."/>
<person name="Reiman M."/>
<person name="Jukkola-Vuorinen A."/>
<person name="Mustonen A."/>
<person name="Kere J."/>
<person name="Aaltonen L.A."/>
<person name="Kosma V.-M."/>
<person name="Kataja V."/>
<person name="Soini Y."/>
<person name="Drapkin R.I."/>
<person name="Livingston D.M."/>
<person name="Winqvist R."/>
</authorList>
<dbReference type="PubMed" id="17287723"/>
<dbReference type="DOI" id="10.1038/nature05609"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO BREAST CANCER</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="159" last="161">
<title>Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.</title>
<authorList>
<person name="Xia B."/>
<person name="Dorsman J.C."/>
<person name="Ameziane N."/>
<person name="de Vries Y."/>
<person name="Rooimans M.A."/>
<person name="Sheng Q."/>
<person name="Pals G."/>
<person name="Errami A."/>
<person name="Gluckman E."/>
<person name="Llera J."/>
<person name="Wang W."/>
<person name="Livingston D.M."/>
<person name="Joenje H."/>
<person name="de Winter J.P."/>
</authorList>
<dbReference type="PubMed" id="17200672"/>
<dbReference type="DOI" id="10.1038/ng1942"/>
</citation>
<scope>INVOLVEMENT IN FANCN</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="18302" last="18310">
<title>PALB2 regulates recombinational repair through chromatin association and oligomerization.</title>
<authorList>
<person name="Sy S.M."/>
<person name="Huen M.S."/>
<person name="Zhu Y."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19423707"/>
<dbReference type="DOI" id="10.1074/jbc.m109.016717"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH BRCA2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7155" last="7160">
<title>PALB2 is an integral component of the BRCA complex required for homologous recombination repair.</title>
<authorList>
<person name="Sy S.M."/>
<person name="Huen M.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19369211"/>
<dbReference type="DOI" id="10.1073/pnas.0811159106"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A BRCA COMPLEX WITH BRCA1 AND BRCA2</scope>
<scope>INTERACTION WITH BRCA1</scope>
<scope>MUTAGENESIS OF LYS-14; LEU-21; TYR-28; LEU-35 AND GLU-42</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Science" volume="324" first="217" last="217">
<title>Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.</title>
<authorList>
<person name="Jones S."/>
<person name="Hruban R.H."/>
<person name="Kamiyama M."/>
<person name="Borges M."/>
<person name="Zhang X."/>
<person name="Parsons D.W."/>
<person name="Lin J.C."/>
<person name="Palmisano E."/>
<person name="Brune K."/>
<person name="Jaffee E.M."/>
<person name="Iacobuzio-Donahue C.A."/>
<person name="Maitra A."/>
<person name="Parmigiani G."/>
<person name="Kern S.E."/>
<person name="Velculescu V.E."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B."/>
<person name="Eshleman J.R."/>
<person name="Goggins M."/>
<person name="Klein A.P."/>
</authorList>
<dbReference type="PubMed" id="19264984"/>
<dbReference type="DOI" id="10.1126/science.1171202"/>
</citation>
<scope>INVOLVEMENT IN PNCA3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="1124" last="1130">
<title>MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks.</title>
<authorList>
<person name="Hayakawa T."/>
<person name="Zhang F."/>
<person name="Hayakawa N."/>
<person name="Ohtani Y."/>
<person name="Shinmyozu K."/>
<person name="Nakayama J."/>
<person name="Andreassen P.R."/>
</authorList>
<dbReference type="PubMed" id="20332121"/>
<dbReference type="DOI" id="10.1242/jcs.060178"/>
</citation>
<scope>INTERACTION WITH MORF4L1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1247" last="1254">
<title>Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.</title>
<authorList>
<person name="Buisson R."/>
<person name="Dion-Cote A.M."/>
<person name="Coulombe Y."/>
<person name="Launay H."/>
<person name="Cai H."/>
<person name="Stasiak A.Z."/>
<person name="Stasiak A."/>
<person name="Xia B."/>
<person name="Masson J.Y."/>
</authorList>
<dbReference type="PubMed" id="20871615"/>
<dbReference type="DOI" id="10.1038/nsmb.1915"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1255" last="1259">
<title>Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.</title>
<authorList>
<person name="Dray E."/>
<person name="Etchin J."/>
<person name="Wiese C."/>
<person name="Saro D."/>
<person name="Williams G.J."/>
<person name="Hammel M."/>
<person name="Yu X."/>
<person name="Galkin V.E."/>
<person name="Liu D."/>
<person name="Tsai M.S."/>
<person name="Sy S.M."/>
<person name="Schild D."/>
<person name="Egelman E."/>
<person name="Chen J."/>
<person name="Sung P."/>
</authorList>
<dbReference type="PubMed" id="20871616"/>
<dbReference type="DOI" id="10.1038/nsmb.1916"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51 AND RAD51AP1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="EMBO Rep." volume="13" first="135" last="141">
<title>ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair.</title>
<authorList>
<person name="Bleuyard J.Y."/>
<person name="Buisson R."/>
<person name="Masson J.Y."/>
<person name="Esashi F."/>
</authorList>
<dbReference type="PubMed" id="22193777"/>
<dbReference type="DOI" id="10.1038/embor.2011.243"/>
</citation>
<scope>ASSOCIATION WITH CHROMATIN</scope>
<scope>ASSOCIATION WITH NUCLEOSOMES</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="674" last="680">
<title>Rare germline mutations in PALB2 and breast cancer risk: a population-based study.</title>
<authorList>
<person name="Tischkowitz M."/>
<person name="Capanu M."/>
<person name="Sabbaghian N."/>
<person name="Li L."/>
<person name="Liang X."/>
<person name="Vallee M.P."/>
<person name="Tavtigian S.V."/>
<person name="Concannon P."/>
<person name="Foulkes W.D."/>
<person name="Bernstein L."/>
<person name="Bernstein J.L."/>
<person name="Begg C.B."/>
</authorList>
<dbReference type="PubMed" id="22241545"/>
<dbReference type="DOI" id="10.1002/humu.22022"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO BREAST CANCER</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Nucleic Acids Res." volume="40" first="10312" last="10323">
<title>PALB2 self-interaction controls homologous recombination.</title>
<authorList>
<person name="Buisson R."/>
<person name="Masson J.Y."/>
</authorList>
<dbReference type="PubMed" id="22941656"/>
<dbReference type="DOI" id="10.1093/nar/gks807"/>
</citation>
<scope>FUNCTION</scope>
<scope>SELF-ASSOCIATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-172; SER-190; SER-285; SER-376; SER-387; SER-454; SER-660 AND SER-781</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="4803" last="4812">
<title>Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.</title>
<authorList>
<person name="Park J.Y."/>
<person name="Singh T.R."/>
<person name="Nassar N."/>
<person name="Zhang F."/>
<person name="Freund M."/>
<person name="Hanenberg H."/>
<person name="Meetei A.R."/>
<person name="Andreassen P.R."/>
</authorList>
<dbReference type="PubMed" id="24141787"/>
<dbReference type="DOI" id="10.1038/onc.2013.421"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRCA2; RAD51C; RAD51 AND XRCC3</scope>
<scope>MUTAGENESIS OF THR-1030</scope>
<scope>CHARACTERIZATION OF VARIANTS TRP-939 AND PRO-1143</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="Cell Rep." volume="6" first="553" last="564">
<title>Breast cancer proteins PALB2 and BRCA2 stimulate polymerase eta in recombination-associated DNA synthesis at blocked replication forks.</title>
<authorList>
<person name="Buisson R."/>
<person name="Niraj J."/>
<person name="Pauty J."/>
<person name="Maity R."/>
<person name="Zhao W."/>
<person name="Coulombe Y."/>
<person name="Sung P."/>
<person name="Masson J.Y."/>
</authorList>
<dbReference type="PubMed" id="24485656"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.01.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH POLH</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2017" name="Oncogene" volume="36" first="4161" last="4170">
<title>Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.</title>
<authorList>
<person name="Foo T.K."/>
<person name="Tischkowitz M."/>
<person name="Simhadri S."/>
<person name="Boshari T."/>
<person name="Zayed N."/>
<person name="Burke K.A."/>
<person name="Berman S.H."/>
<person name="Blecua P."/>
<person name="Riaz N."/>
<person name="Huo Y."/>
<person name="Ding Y.C."/>
<person name="Neuhausen S.L."/>
<person name="Weigelt B."/>
<person name="Reis-Filho J.S."/>
<person name="Foulkes W.D."/>
<person name="Xia B."/>
</authorList>
<dbReference type="PubMed" id="28319063"/>
<dbReference type="DOI" id="10.1038/onc.2017.46"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH BRCA1; BRCA2 AND RAD51</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT BC PRO-35</scope>
<scope>CHARACTERIZATION OF VARIANT BC PRO-35</scope>
<scope>CHARACTERIZATION OF VARIANTS ARG-18; CYS-28 AND HIS-37</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="EMBO Rep." volume="10" first="990" last="996">
<title>Structural basis for recruitment of BRCA2 by PALB2.</title>
<authorList>
<person name="Oliver A.W."/>
<person name="Swift S."/>
<person name="Lord C.J."/>
<person name="Ashworth A."/>
<person name="Pearl L.H."/>
</authorList>
<dbReference type="PubMed" id="19609323"/>
<dbReference type="DOI" id="10.1038/embor.2009.126"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 835-1186 ALONE AND IN COMPLEX WITH A BRCA2 PEPTIDE</scope>
<scope>DOMAIN WD REPEATS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Nature" volume="456" first="66" last="72">
<title>DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.</title>
<authorList>
<person name="Ley T.J."/>
<person name="Mardis E.R."/>
<person name="Ding L."/>
<person name="Fulton B."/>
<person name="McLellan M.D."/>
<person name="Chen K."/>
<person name="Dooling D."/>
<person name="Dunford-Shore B.H."/>
<person name="McGrath S."/>
<person name="Hickenbotham M."/>
<person name="Cook L."/>
<person name="Abbott R."/>
<person name="Larson D.E."/>
<person name="Koboldt D.C."/>
<person name="Pohl C."/>
<person name="Smith S."/>
<person name="Hawkins A."/>
<person name="Abbott S."/>
<person name="Locke D."/>
<person name="Hillier L.W."/>
<person name="Miner T."/>
<person name="Fulton L."/>
<person name="Magrini V."/>
<person name="Wylie T."/>
<person name="Glasscock J."/>
<person name="Conyers J."/>
<person name="Sander N."/>
<person name="Shi X."/>
<person name="Osborne J.R."/>
<person name="Minx P."/>
<person name="Gordon D."/>
<person name="Chinwalla A."/>
<person name="Zhao Y."/>
<person name="Ries R.E."/>
<person name="Payton J.E."/>
<person name="Westervelt P."/>
<person name="Tomasson M.H."/>
<person name="Watson M."/>
<person name="Baty J."/>
<person name="Ivanovich J."/>
<person name="Heath S."/>
<person name="Shannon W.D."/>
<person name="Nagarajan R."/>
<person name="Walter M.J."/>
<person name="Link D.C."/>
<person name="Graubert T.A."/>
<person name="DiPersio J.F."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="18987736"/>
<dbReference type="DOI" id="10.1038/nature07485"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] SER-864</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="E2176" last="E2188">
<title>Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.</title>
<authorList>
<person name="Hellebrand H."/>
<person name="Sutter C."/>
<person name="Honisch E."/>
<person name="Gross E."/>
<person name="Wappenschmidt B."/>
<person name="Schem C."/>
<person name="Deissler H."/>
<person name="Ditsch N."/>
<person name="Gress V."/>
<person name="Kiechle M."/>
<person name="Bartram C.R."/>
<person name="Schmutzler R.K."/>
<person name="Niederacher D."/>
<person name="Arnold N."/>
<person name="Meindl A."/>
</authorList>
<dbReference type="PubMed" id="21618343"/>
<dbReference type="DOI" id="10.1002/humu.21478"/>
</citation>
<scope>VARIANTS TYR-46; GLY-219; CYS-334; SER-337; GLN-414; MET-425; THR-491; ARG-515; ARG-559; GLN-672; VAL-712; LEU-728; SER-864; ALA-917; MET-932; TRP-939; VAL-966; GLU-998; THR-1025; ALA-1043; GLY-1075; ALA-1105; HIS-1114; PRO-1143 AND TYR-1170</scope>
</reference>
<comment type="function">
<text evidence="8 13 14 17 18 22 23 24 25">Plays a critical role in homologous recombination repair (HRR) through its ability to recruit BRCA2 and RAD51 to DNA breaks (PubMed:16793542, PubMed:19423707, PubMed:19369211, PubMed:22941656, PubMed:24141787, PubMed:28319063). Strongly stimulates the DNA strand-invasion activity of RAD51, stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide and helps RAD51 to overcome the suppressive effect of replication protein A (RPA) (PubMed:20871615). Functionally cooperates with RAD51AP1 in promoting of D-loop formation by RAD51 (PubMed:20871616). Serves as the molecular scaffold in the formation of the BRCA1-PALB2-BRCA2 complex which is essential for homologous recombination (PubMed:19369211). Via its WD repeats is proposed to scaffold a HR complex containing RAD51C and BRCA2 which is thought to play a role in HR-mediated DNA repair (PubMed:24141787). Essential partner of BRCA2 that promotes the localization and stability of BRCA2 (PubMed:16793542). Also enables its recombinational repair and checkpoint functions of BRCA2 (PubMed:16793542). May act by promoting stable association of BRCA2 with nuclear structures, allowing BRCA2 to escape the effects of proteasome-mediated degradation (PubMed:16793542). Binds DNA with high affinity for D loop, which comprises single-stranded, double-stranded and branched DNA structures (PubMed:20871616). May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with BRCA2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity (PubMed:24485656).</text>
</comment>
<comment type="subunit">
<text evidence="8 13 14 15 16 17 18 23 24 25">Homooligomer; dissociated upon DNA damage thus allowing association with BRCA1 (PubMed:19423707, PubMed:28319063). Oligomerization is essential for its focal accumulation at DNA breaks (PubMed:19423707). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts with BRCA1 and this interaction is essential for its function in HRR (PubMed:19369211, PubMed:28319063). Interacts with RAD51AP1 and MORF4L1/MRG15 (PubMed:20332121, PubMed:20871616). Interacts with BRCA2, RAD51C, RAD51 and XRCC3; the interactions are direct and it may serve as a scaffold for a HR complex containing PALB2, BRCA2, RAD51C, RAD51 and XRCC3 (PubMed:28319063, PubMed:16793542, PubMed:19423707, PubMed:19609323, PubMed:20871615, PubMed:20871616, PubMed:24141787). Interacts with POLH; the interaction is direct (PubMed:24485656).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>27</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-79792">
<id>P51587</id>
<label>BRCA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-751001">
<id>Q14145</id>
<label>KEAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-10288852">
<id>Q9UBU8-2</id>
<label>MORF4L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-2827270">
<id>Q9Y253</id>
<label>POLH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-297202">
<id>Q06609</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-1178743">
<id>Q96B01-2</id>
<label>RAD51AP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-2267048">
<id>O43502</id>
<label>RAD51C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-306876">
<id>P51784</id>
<label>USP11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
</interactant>
<interactant intactId="EBI-2849976">
<id>O43542</id>
<label>XRCC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 25">Nucleus</location>
</subcellularLocation>
<text evidence="8 25">Colocalizes with BRCA2 and BRCA1 in nuclear foci.</text>
</comment>
<comment type="domain">
<text evidence="15">Interaction with BRCA2 occurs through a hydrophobic pocket at the crossover between WD repeats 4 and 5.</text>
</comment>
<comment type="domain">
<text evidence="15 22">The coiled coil domain mediates self-association.</text>
</comment>
<comment type="domain">
<text evidence="15 20">The chromatin-association motif (ChAM) mediates association with chromatin, probably through nucleosome core particles, independently from binding to D loop, ssDNA or dsDNA structures.</text>
</comment>
<comment type="disease" evidence="10 21 25">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text evidence="21">Disease susceptibility is associated with variations affecting the gene represented in this entry. Breast cancer susceptibility is strongly associated with PALB2 truncating mutations. Conversely, rare missense mutations do not strongly influence breast cancer risk (PubMed:22241545).</text>
</comment>
<comment type="disease" evidence="9">
<disease id="DI-01604">
<name>Fanconi anemia complementation group N</name>
<acronym>FANCN</acronym>
<description>A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.</description>
<dbReference type="MIM" id="610832"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12">
<disease id="DI-02848">
<name>Pancreatic cancer 3</name>
<acronym>PNCA3</acronym>
<description>A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.</description>
<dbReference type="MIM" id="613348"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="26">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB15140" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="AL834425">
<property type="protein sequence ID" value="CAD39086.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR749637">
<property type="protein sequence ID" value="CAH18431.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008870">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471145">
<property type="protein sequence ID" value="EAW55813.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC044254">
<property type="protein sequence ID" value="AAH44254.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK025469">
<property type="protein sequence ID" value="BAB15140.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK097533">
<property type="protein sequence ID" value="BAC05090.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32406.1"/>
<dbReference type="RefSeq" id="NP_078951.2">
<property type="nucleotide sequence ID" value="NM_024675.3"/>
</dbReference>
<dbReference type="PDB" id="2W18">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=835-1186"/>
</dbReference>
<dbReference type="PDB" id="3EU7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=835-1186"/>
</dbReference>
<dbReference type="PDBsum" id="2W18"/>
<dbReference type="PDBsum" id="3EU7"/>
<dbReference type="SMR" id="Q86YC2"/>
<dbReference type="BioGRID" id="122843">
<property type="interactions" value="56"/>
</dbReference>
<dbReference type="DIP" id="DIP-38427N"/>
<dbReference type="ELM" id="Q86YC2"/>
<dbReference type="IntAct" id="Q86YC2">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="MINT" id="Q86YC2"/>
<dbReference type="STRING" id="9606.ENSP00000261584"/>
<dbReference type="iPTMnet" id="Q86YC2"/>
<dbReference type="PhosphoSitePlus" id="Q86YC2"/>
<dbReference type="BioMuta" id="PALB2"/>
<dbReference type="DMDM" id="74727919"/>
<dbReference type="CPTAC" id="CPTAC-3284"/>
<dbReference type="EPD" id="Q86YC2"/>
<dbReference type="jPOST" id="Q86YC2"/>
<dbReference type="MassIVE" id="Q86YC2"/>
<dbReference type="MaxQB" id="Q86YC2"/>
<dbReference type="PaxDb" id="Q86YC2"/>
<dbReference type="PeptideAtlas" id="Q86YC2"/>
<dbReference type="PRIDE" id="Q86YC2"/>
<dbReference type="ProteomicsDB" id="70395"/>
<dbReference type="Antibodypedia" id="26008">
<property type="antibodies" value="229 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="Q86YC2">
<property type="antibodies" value="1 antibody"/>
</dbReference>
<dbReference type="DNASU" id="79728"/>
<dbReference type="Ensembl" id="ENST00000261584">
<property type="protein sequence ID" value="ENSP00000261584"/>
<property type="gene ID" value="ENSG00000083093"/>
</dbReference>
<dbReference type="GeneID" id="79728"/>
<dbReference type="KEGG" id="hsa:79728"/>
<dbReference type="UCSC" id="uc002dlx.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="79728"/>
<dbReference type="DisGeNET" id="79728"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000083093.9"/>
<dbReference type="GeneCards" id="PALB2"/>
<dbReference type="GeneReviews" id="PALB2"/>
<dbReference type="HGNC" id="HGNC:26144">
<property type="gene designation" value="PALB2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000083093">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="PALB2"/>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="610355">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610832">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613348">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q86YC2"/>
<dbReference type="OpenTargets" id="ENSG00000083093"/>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="84">
<property type="disease" value="Fanconi anemia"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="227535">
<property type="disease" value="Hereditary breast cancer"/>
</dbReference>
<dbReference type="PharmGKB" id="PA162398608"/>
<dbReference type="eggNOG" id="ENOG502QRAP">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000014423"/>
<dbReference type="HOGENOM" id="CLU_008217_0_0_1"/>
<dbReference type="InParanoid" id="Q86YC2"/>
<dbReference type="KO" id="K10897"/>
<dbReference type="OMA" id="NQTHSCT"/>
<dbReference type="OrthoDB" id="710645at2759"/>
<dbReference type="PhylomeDB" id="Q86YC2"/>
<dbReference type="TreeFam" id="TF351544"/>
<dbReference type="PathwayCommons" id="Q86YC2"/>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="SIGNOR" id="Q86YC2"/>
<dbReference type="BioGRID-ORCS" id="79728">
<property type="hits" value="186 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PALB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q86YC2"/>
<dbReference type="GeneWiki" id="PALB2"/>
<dbReference type="GenomeRNAi" id="79728"/>
<dbReference type="Pharos" id="Q86YC2">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q86YC2"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="Q86YC2">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000083093">
<property type="expression patterns" value="Expressed in secondary oocyte and 189 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q86YC2">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q86YC2">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009887">
<property type="term" value="P:animal organ morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048568">
<property type="term" value="P:embryonic organ development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001833">
<property type="term" value="P:inner cell mass cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007498">
<property type="term" value="P:mesoderm development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036342">
<property type="term" value="P:post-anal tail morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001756">
<property type="term" value="P:somitogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00249"/>
<dbReference type="InterPro" id="IPR042417">
<property type="entry name" value="PALB2"/>
</dbReference>
<dbReference type="InterPro" id="IPR031920">
<property type="entry name" value="PALB2_WD40"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036322">
<property type="entry name" value="WD40_repeat_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR14662">
<property type="entry name" value="PTHR14662"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16756">
<property type="entry name" value="PALB2_WD40"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50978">
<property type="entry name" value="SSF50978"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0923">Fanconi anemia</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0853">WD repeat</keyword>
<feature type="chain" description="Partner and localizer of BRCA2" id="PRO_0000252391">
<location>
<begin position="1"/>
<end position="1186"/>
</location>
</feature>
<feature type="repeat" description="WD 1">
<location>
<begin position="854"/>
<end position="915"/>
</location>
</feature>
<feature type="repeat" description="WD 2">
<location>
<begin position="917"/>
<end position="961"/>
</location>
</feature>
<feature type="repeat" description="WD 3">
<location>
<begin position="962"/>
<end position="1009"/>
</location>
</feature>
<feature type="repeat" description="WD 4">
<location>
<begin position="1010"/>
<end position="1052"/>
</location>
</feature>
<feature type="repeat" description="WD 5">
<location>
<begin position="1058"/>
<end position="1109"/>
</location>
</feature>
<feature type="repeat" description="WD 6">
<location>
<begin position="1115"/>
<end position="1153"/>
</location>
</feature>
<feature type="repeat" description="WD 7">
<location>
<begin position="1155"/>
<end position="1186"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding (with the preference D loop &gt; dsDNA &gt; ssDNA)">
<location>
<begin position="1"/>
<end position="579"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with BRCA1" evidence="13">
<location>
<begin position="1"/>
<end position="319"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RAD51">
<location>
<begin position="1"/>
<end position="200"/>
</location>
</feature>
<feature type="region of interest" description="Required for its oligomerization and is important for its focal concentration at DNA damage sites">
<location>
<begin position="1"/>
<end position="160"/>
</location>
</feature>
<feature type="region of interest" description="ChAM (Chromatin-association motif); required for chromatin association, mediates nucleosome association">
<location>
<begin position="395"/>
<end position="446"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with POLH and POLH DNA synthesis stimulation" evidence="24">
<location>
<begin position="775"/>
<end position="1186"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RAD51, BRCA2 and POLH" evidence="24">
<location>
<begin position="853"/>
<end position="1186"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="7">
<location>
<begin position="9"/>
<end position="41"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="190"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="285"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 6">
<location>
<position position="376"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6">
<location>
<position position="387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="454"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="660"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="781"/>
</location>
</feature>
<feature type="sequence variant" description="Decreases double-stranded DNA break-initiated homologous recombination; dbSNP:rs138789658." id="VAR_079842" evidence="25">
<original>K</original>
<variation>R</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="Abrogates the interaction with BRCA1; decreases double-stranded DNA break-initiated homologous recombination; reduces PALB2 and RAD51 localization to ionizing radiation-induced foci; may weaken homooligomerization; dbSNP:rs515726129." id="VAR_079843" evidence="25">
<original>Y</original>
<variation>C</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abrogates the interaction with BRCA1; abrogates double-stranded DNA break-initiated homologous recombination; abrogates PALB2 and RAD51 localization to ionizing radiation-induced foci; may weaken homooligomerization; dbSNP:rs141047069." id="VAR_079844" evidence="25">
<original>L</original>
<variation>P</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="Decreases double-stranded DNA break-initiated homologous recombination; dbSNP:rs202194596." id="VAR_079845" evidence="25">
<original>R</original>
<variation>H</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_066361" evidence="19">
<original>H</original>
<variation>Y</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45594034." id="VAR_066362" evidence="19">
<original>D</original>
<variation>G</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3809683." id="VAR_032959">
<original>I</original>
<variation>V</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200620434." id="VAR_066363" evidence="19">
<original>Y</original>
<variation>C</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45494092." id="VAR_066364" evidence="19">
<original>L</original>
<variation>S</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs749461008." id="VAR_066365" evidence="19">
<original>R</original>
<variation>Q</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs576081828." id="VAR_066366" evidence="19">
<original>V</original>
<variation>M</variation>
<location>
<position position="425"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs577969558." id="VAR_066367" evidence="19">
<original>A</original>
<variation>T</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs515726072." id="VAR_066368" evidence="19">
<original>K</original>
<variation>R</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs152451." id="VAR_066369" evidence="19">
<original>Q</original>
<variation>R</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45532440." id="VAR_066370" evidence="19">
<original>E</original>
<variation>Q</variation>
<location>
<position position="672"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs141458731." id="VAR_066371" evidence="19">
<original>A</original>
<variation>V</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_066372" evidence="19">
<original>F</original>
<variation>L</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45568339." id="VAR_054150" evidence="11 19">
<original>P</original>
<variation>S</variation>
<location>
<position position="864"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs763645981." id="VAR_066373" evidence="19">
<original>V</original>
<variation>A</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45624036." id="VAR_066374" evidence="19">
<original>V</original>
<variation>M</variation>
<location>
<position position="932"/>
</location>
</feature>
<feature type="sequence variant" description="May be associated with breast cancer susceptibility; reduces interaction with BRCA2, RAD51 and XRCC3; decreases double-stranded DNA break-initiated homologous recombination; increases sensitivity to IR; dbSNP:rs45478192." id="VAR_066375" evidence="19 23">
<original>L</original>
<variation>W</variation>
<location>
<position position="939"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs786204248." id="VAR_066376" evidence="19">
<original>I</original>
<variation>V</variation>
<location>
<position position="966"/>
</location>
</feature>
<feature type="sequence variant" description="May be associated with breast cancer susceptibility; dbSNP:rs45551636." id="VAR_066377" evidence="19">
<original>G</original>
<variation>E</variation>
<location>
<position position="998"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs746872839." id="VAR_066378" evidence="19">
<original>A</original>
<variation>T</variation>
<location>
<position position="1025"/>
</location>
</feature>
<feature type="sequence variant" description="May be associated with breast cancer susceptibility; reduces interaction with BRCA2, RAD51C, RAD51 and XRCC3; decreases double-stranded DNA break-initiated homologous recombination; increases sensitivity to IR; dbSNP:rs377713277." id="VAR_066379" evidence="19">
<original>G</original>
<variation>A</variation>
<location>
<position position="1043"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_066380" evidence="19">
<original>S</original>
<variation>G</variation>
<location>
<position position="1075"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_066381" evidence="19">
<original>V</original>
<variation>A</variation>
<location>
<position position="1105"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1567206753." id="VAR_066382" evidence="19">
<original>Q</original>
<variation>H</variation>
<location>
<position position="1114"/>
</location>
</feature>
<feature type="sequence variant" description="May be associated with breast cancer susceptibility; dbSNP:rs62625284." id="VAR_066383" evidence="19 23">
<original>L</original>
<variation>P</variation>
<location>
<position position="1143"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200283306." id="VAR_066384" evidence="19">
<original>H</original>
<variation>Y</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BRCA1 but no effect on interaction with BRCA2." evidence="13">
<original>K</original>
<variation>A</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BRCA1 but no effect on interaction with BRCA2." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BRCA1 but no effect on interaction with BRCA2." evidence="13">
<original>Y</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BRCA1 but no effect on interaction with BRCA2." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BRCA1 but no effect on interaction with BRCA2." evidence="13">
<original>E</original>
<variation>A</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="Unstable and promotes protein degradation; reduces interaction with RAD51C and RAD51." evidence="23">
<original>T</original>
<variation>I</variation>
<location>
<position position="1030"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="855"/>
<end position="861"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="869"/>
<end position="877"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="884"/>
<end position="913"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="919"/>
<end position="922"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="932"/>
<end position="936"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="938"/>
<end position="947"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="958"/>
<end position="972"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="973"/>
<end position="975"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="976"/>
<end position="984"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="988"/>
<end position="994"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1000"/>
<end position="1006"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1013"/>
<end position="1020"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1025"/>
<end position="1030"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1033"/>
<end position="1039"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1040"/>
<end position="1042"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1045"/>
<end position="1050"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1053"/>
<end position="1055"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1059"/>
<end position="1066"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1069"/>
<end position="1075"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1090"/>
<end position="1096"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1097"/>
<end position="1100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1101"/>
<end position="1108"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1118"/>
<end position="1124"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1127"/>
<end position="1132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1137"/>
<end position="1141"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1142"/>
<end position="1144"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1146"/>
<end position="1151"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1161"/>
<end position="1164"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1166"/>
<end position="1174"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1180"/>
<end position="1185"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W18"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EU7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16793542"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17200672"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17287723"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18987736"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19264984"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19369211"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19423707"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19609323"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20332121"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20871615"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20871616"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21618343"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22193777"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22241545"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22941656"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24141787"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24485656"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28319063"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<sequence length="1186" mass="131295" checksum="215EC32291315FA2" modified="2003-06-01" version="1">MDEPPGKPLSCEEKEKLKEKLAFLKREYSKTLARLQRAQRAEKIKHSIKKTVEEQDCLSQQDLSPQLKHSEPKNKICVYDKLHIKTHLDEETGEKTSITLDVGPESFNPGDGPGGLPIQRTDDTQEHFPHRVSDPSGEQKQKLPSRRKKQQKRTFISQERDCVFGTDSLRLSGKRLKEQEEISSKNPARSPVTEIRTHLLSLKSELPDSPEPVTEINEDSVLIPPTAQPEKGVDTFLRRPNFTRATTVPLQTLSDSGSSQHLEHIPPKGSSELTTHDLKNIRFTSPVSLEAQGKKMTVSTDNLLVNKAISKSGQLPTSSNLEANISCSLNELTYNNLPANENQNLKEQNQTEKSLKSPSDTLDGRNENLQESEILSQPKSLSLEATSPLSAEKHSCTVPEGLLFPAEYYVRTTRSMSNCQRKVAVEAVIQSHLDVKKKGFKNKNKDASKNLNLSNEETDQSEIRMSGTCTGQPSSRTSQKLLSLTKVSSPAGPTEDNDLSRKAVAQAPGRRYTGKRKSACTPASDHCEPLLPTSSLSIVNRSKEEVTSHKYQHEKLFIQVKGKKSRHQKEDSLSWSNSAYLSLDDDAFTAPFHRDGMLSLKQLLSFLSITDFQLPDEDFGPLKLEKVKSCSEKPVEPFESKMFGERHLKEGSCIFPEELSPKRMDTEMEDLEEDLIVLPGKSHPKRPNSQSQHTKTGLSSSILLYTPLNTVAPDDNDRPTTDMCSPAFPILGTTPAFGPQGSYEKASTEVAGRTCCTPQLAHLKDSVCLASDTKQFDSSGSPAKPHTTLQVSGRQGQPTCDCDSVPPGTPPPIESFTFKENQLCRNTCQELHKHSVEQTETAELPASDSINPGNLQLVSELKNPSGSCSVDVSAMFWERAGCKEPCIITACEDVVSLWKALDAWQWEKLYTWHFAEVPVLQIVPVPDVYNLVCVALGNLEIREIRALFCSSDDESEKQVLLKSGNIKAVLGLTKRRLVSSSGTLSDQQVEVMTFAEDGGGKENQFLMPPEETILTFAEVQGMQEALLGTTIMNNIVIWNLKTGQLLKKMHIDDSYQASVCHKAYSEMGLLFIVLSHPCAKESESLRSPVFQLIVINPKTTLSVGVMLYCLPPGQAGRFLEGDVKDHCAAAILTSGTIAIWDLLLGQCTALLPPVSDQHWSFVKWSGTDSHLLAGQKDGNIFVYHYS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

